BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32369505)

  • 21. A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.
    Kountouras J; Doulberis M; Papaefthymiou A; Polyzos SA; Vardaka E; Tzivras D; Dardiotis E; Deretzi G; Giartza-Taxidou E; Grigoriadis S; Katsinelos P
    Ann N Y Acad Sci; 2019 Sep; 1452(1):12-17. PubMed ID: 31310338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Bus P; Kestens C; Ten Kate FJ; Peters W; Drenth JP; Roodhart JM; Siersema PD; van Baal JW
    J Gastroenterol; 2016 Jun; 51(6):560-70. PubMed ID: 26585599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
    Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
    World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
    Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
    Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
    Hao Y; Karaoz U; Yang L; Yachimski PS; Tseng W; Nossa CW; Ye W; Tseng M; Poles M; Francois F; Traube M; Brown SM; Chen Y; Torralba M; Peek RM; Brodie EL; Pei Z
    Int J Cancer; 2022 Nov; 151(10):1703-1716. PubMed ID: 35751398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic correlation between the expression of the DNA repair enzyme N-methylpurine DNA glycosylase and esophageal adenocarcinoma onset: a retrospective pilot study.
    Zaïr ZM; Johnson GE; Griffiths AP; Jenkins GJ
    Dis Esophagus; 2013 Aug; 26(6):644-50. PubMed ID: 23137018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?
    Blackett KL; Siddhi SS; Cleary S; Steed H; Miller MH; Macfarlane S; Macfarlane GT; Dillon JF
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1084-92. PubMed ID: 23600758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barrett's esophagus and esophageal cancer: Links to microbes and the microbiome.
    Ajayi TA; Cantrell S; Spann A; Garman KS
    PLoS Pathog; 2018 Dec; 14(12):e1007384. PubMed ID: 30571768
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.
    Peters BA; Wu J; Pei Z; Yang L; Purdue MP; Freedman ND; Jacobs EJ; Gapstur SM; Hayes RB; Ahn J
    Cancer Res; 2017 Dec; 77(23):6777-6787. PubMed ID: 29196415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for esophageal cancer: emphasis on infectious agents.
    El-Zimaity H; Di Pilato V; Novella Ringressi M; Brcic I; Rajendra S; Langer R; Dislich B; Tripathi M; Guindi M; Riddell R
    Ann N Y Acad Sci; 2018 Dec; 1434(1):319-332. PubMed ID: 29851130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
    Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
    BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.
    Clark GW
    World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINE-1 expression and retrotransposition in Barrett's esophagus and esophageal carcinoma.
    Doucet-O'Hare TT; Rodić N; Sharma R; Darbari I; Abril G; Choi JA; Young Ahn J; Cheng Y; Anders RA; Burns KH; Meltzer SJ; Kazazian HH
    Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4894-900. PubMed ID: 26283398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.